Likewise, the rise of NDUFS8 in HCC was modulated by LYR (leucine/tyrosine/arginine) motif protein 4 [81], helping HCC cells avoid sorafenib and successfully survive [89]. This evidence concerns the gene NDUFS8 and hepatocellular carcinoma.